Project title

2-OXOGLUTARATE-DEPENDENT DIOXYGENASES IN DISEASES

We have shown that activating the body's oxygen deficiency response could be a novel treatment for obesity and metabolic syndrome, of which a quarter of the world's adult population suffers. The activation can be carried out with a small molecule drug, which is an enzyme inhibitor. Similar drugs will be available to treat anemia.